184 related articles for article (PubMed ID: 31638200)
1. Upregulated expression of eIF3C is associated with malignant behavior in renal cell carcinoma.
Fan M; Wang K; Wei X; Yao H; Chen Z; He X
Int J Oncol; 2019 Dec; 55(6):1385-1395. PubMed ID: 31638200
[TBL] [Abstract][Full Text] [Related]
2. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway.
Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W
Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645
[TBL] [Abstract][Full Text] [Related]
3. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
Li Z; Ma Z; Xu X
Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
[TBL] [Abstract][Full Text] [Related]
4. EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis.
Ding X; Hou L; Zhang H; Chen Z; Liu Z; Gong J; Tang Z; Hu R
Dis Markers; 2022; 2022():9464094. PubMed ID: 36157221
[TBL] [Abstract][Full Text] [Related]
5. Long non‑coding RNA PLK1S1 was associated with renal cell carcinoma progression by interacting with microRNA‑653 and altering C‑X‑C chemokine receptor 5 expression.
Li W; Yang D; Zhang Y; Zhao S; Li D; Liu M
Oncol Rep; 2020 Nov; 44(5):1985-1996. PubMed ID: 33000253
[TBL] [Abstract][Full Text] [Related]
6. RASA1 inhibits the progression of renal cell carcinoma by decreasing the expression of miR-223-3p and promoting the expression of FBXW7.
Zhang RL; Aimudula A; Dai JH; Bao YX
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32588875
[TBL] [Abstract][Full Text] [Related]
7. miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression.
Jiang K; Sun F; Zhu J; Luo G; Ban Y; Zhang P
Mol Genet Genomic Med; 2019 Aug; 7(8):e833. PubMed ID: 31250570
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Significance of
Hu J; Luo H; Xu Y; Luo G; Xu S; Zhu J; Song D; Sun Z; Kuang Y
Cancer Invest; 2019; 37(4-5):199-208. PubMed ID: 31181967
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic initiation factor 3C silencing inhibits cell proliferation and promotes apoptosis in human glioma.
Hao J; Wang Z; Wang Y; Liang Z; Zhang X; Zhao Z; Jiao B
Oncol Rep; 2015 Jun; 33(6):2954-62. PubMed ID: 25823503
[TBL] [Abstract][Full Text] [Related]
10. Decreasing Eukaryotic Initiation Factor 3C (EIF3C) Suppresses Proliferation and Stimulates Apoptosis in Breast Cancer Cell Lines Through Mammalian Target of Rapamycin (mTOR) Pathway.
Zhao W; Li X; Wang J; Wang C; Jia Y; Yuan S; Huang Y; Shi Y; Tong Z
Med Sci Monit; 2017 Aug; 23():4182-4191. PubMed ID: 28854163
[TBL] [Abstract][Full Text] [Related]
11. Expression and proliferation-promoting role of lymphoid enhancer-binding factor 1 in human clear cell renal carcinoma.
Shang D; Bi R; Han T; Wang D; Tian Y; Liu Y
Cancer Invest; 2014 Aug; 32(7):368-74. PubMed ID: 24897388
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway.
Wang Q; Wu G; Zhang Z; Tang Q; Zheng W; Chen X; Chen F; Li Q; Che X
Int J Oncol; 2018 Nov; 53(5):2278-2288. PubMed ID: 30226576
[TBL] [Abstract][Full Text] [Related]
14. δ-Catenin regulates proliferation and apoptosis in renal cell carcinoma via promoting β-catenin nuclear localization and activating its downstream target genes.
Ju L; Shan L; Yin B; Song Y
Cancer Med; 2020 Mar; 9(6):2201-2212. PubMed ID: 31991069
[TBL] [Abstract][Full Text] [Related]
15. EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling.
Pan XW; Chen L; Hong Y; Xu DF; Liu X; Li L; Huang Y; Cui LM; Gan SS; Yang QW; Huang H; Qu FJ; Ye JQ; Wang LH; Cui XG
Int J Oncol; 2016 Jun; 48(6):2580-90. PubMed ID: 27035563
[TBL] [Abstract][Full Text] [Related]
16. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells.
Wang X; Lu Y; Tuo Z; Zhou H; Zhang Y; Cao Z; Peng L; Yu D; Bi L
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836
[TBL] [Abstract][Full Text] [Related]
17. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
[TBL] [Abstract][Full Text] [Related]
18. Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma.
Li Y; Wang T; Li Y; Chen D; Yu Z; Jin L; Ni L; Yang S; Mao X; Gui Y; Lai Y
Mol Med Rep; 2016 Apr; 13(4):3326-34. PubMed ID: 26935146
[TBL] [Abstract][Full Text] [Related]
19. BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma.
Wan P; Chen Z; Zhong W; Jiang H; Huang Z; Peng D; He Q; Chen N
Oncol Rep; 2020 Dec; 44(6):2475-2486. PubMed ID: 33125143
[TBL] [Abstract][Full Text] [Related]
20. EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.
Huang H; Gao Y; Liu A; Yang X; Huang F; Xu L; Danfeng X; Chen L
EBioMedicine; 2019 Nov; 49():189-201. PubMed ID: 31669222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
